Production (Stage)
Moleculin Biotech, Inc.
MBRX
$0.67
-$0.0201-2.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.40% | 26.89% | -14.77% | 14.02% | 10.80% |
| Total Depreciation and Amortization | -3.10% | -0.79% | 4.84% | 3.20% | 0.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -120.91% | -155.45% | 46.87% | -79.10% | 16.48% |
| Change in Net Operating Assets | 988.89% | -85.76% | 196.35% | -186.48% | 120.78% |
| Cash from Operations | 10.63% | -1.15% | 8.76% | 3.32% | 15.81% |
| Capital Expenditure | 89.52% | 89.52% | -118.60% | -713.33% | -103.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 89.52% | 89.52% | -118.60% | -713.33% | -103.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 214.53% | 11.88% | 3,982.94% | 1,774.41% | 2,754.61% |
| Repurchase of Common Stock | -4.00% | -4.00% | -4.00% | 9.38% | -8.70% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 215.85% | 11.93% | 4,517.74% | 2,093.30% | 3,289.83% |
| Foreign Exchange rate Adjustments | 23.08% | -52.38% | 216.67% | -13.33% | 42.22% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 55.44% | 1.65% | 41.22% | 17.42% | 29.12% |